Can Mobocertinib be purchased in Hong Kong? How much?

Mobocertinib is a drug used to treat non-small cell lung cancer (NSCLC). It belongs to a class of targeted therapies called tyrosine kinase inhibitors, which are used primarily for mutations in the EGFR (epidermal growth factor receptor) gene. Specifically, mobosetinib is used to treat patients with EGFR T790M-positive NSCLC.

Mobotinib is currently on the market in China, but it is not included in medical insurance. Patients need to pay for it in full, so the price is very high. Please consult the local hospital pharmacy for specific prices. Other versions include the ChinaHong Kong version of the original drug Mobotinib, which costs around 7,000 to 8,000 yuan. The generic drug of Mobotinib is mainly a Laotian generic drug. The price is about three to four thousand yuan, which is nearly half cheaper than the original drug. The ingredients of the original drug and the generic drug are the same.

EGFR is a growth factor receptor involved in the regulation of cell growth and division. In some patients with NSCLC, the EGFR gene may be mutated, causing abnormal signaling that promotes tumor cell growth and spread. The mechanism of action of mobosetinib is to inhibit these EGFR mutants, especially the T790M mutation, thereby slowing or inhibiting tumor growth.

Mobosetinib is usually an oral medication prescribed by a doctor based on the patient's specific condition and genetic test results. It is considered an important treatment option, especially for patients who have experienced drug resistance or relapse after receiving other EGFR inhibitors.

However, please note that the name, availability and approval of medicines may vary over time and region, so if you or someone you know needs to use moboxetinib or other medicines, it is recommended to consult a doctor for the latest information and advice.